Mesa Laboratories, Inc. (MLAB) trades at a trailing P/E of 133.8, forward P/E of 10.9. Trailing earnings yield is 0.75%, forward earnings yield 9.16%. Graham Number is $22.64.
Criteria proven by this page:
Overall SharesGrow Score: 37/100 with 0/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 31.1 | 2.23 | 4.10 | 4.10 | 0.66% |
| 2017 | 40.4 | -20.86 | 4.61 | 4.82 | 0.52% |
| 2018 | -187.9 | 1.49 | 5.60 | 5.79 | 0.43% |
| 2019 | 117.4 | -0.34 | 7.89 | 8.52 | 0.28% |
| 2020 | 534.1 | -6.39 | 4.32 | 8.07 | 0.29% |
| 2021 | 370.0 | 3.48 | 2.98 | 9.04 | 0.26% |
| 2022 | 710.0 | -15.62 | 3.37 | 7.21 | 0.25% |
| 2023 | 999.7 | -18.94 | 2.36 | 4.24 | 0.37% |
| 2024 | -2.4 | 0.00 | 4.15 | 2.79 | 0.57% |
| 2025 | -326.3 | 3.29 | 4.03 | 2.67 | 0.54% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $2.97 | $84.66M | $11.17M | 13.2% |
| 2017 | $2.91 | $93.67M | $11.18M | 11.9% |
| 2018 | $-0.79 | $96.18M | $-2.96M | -3.1% |
| 2019 | $1.86 | $103.14M | $7.48M | 7.3% |
| 2020 | $0.31 | $117.69M | $1.35M | 1.1% |
| 2021 | $0.64 | $133.94M | $3.27M | 2.4% |
| 2022 | $0.35 | $184.34M | $1.87M | 1% |
| 2023 | $0.17 | $219.08M | $930K | 0.4% |
| 2024 | $-47.20 | $216.19M | $-254.25M | -117.6% |
| 2025 | $0.00 | $240.98M | $-1.97M | -0.8% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $9.07 | $9.01 – $9.11 | $250.61M | $249.55M – $251.55M | 1 |
| 2027 | $8.52 | $8.47 – $8.56 | $263.03M | $261.91M – $264.01M | 1 |
| 2028 | $2.89 | $2.87 – $2.90 | $274.41M | $272M – $276.81M | 1 |
| 2029 | $0.00 | $0.00 – $0.00 | $287.25M | $286.03M – $288.33M | 0 |
